Is flow dependent dose delivery of a salbutamol-Turbuhaler clinically relevant in asthma patients?

M. E. A. C. Broeders, J. Schalkwijk, J. Molema, H. T. M. Folgering (Groesbeek, The Netherlands)

Source: Annual Congress 2003 - Similarities and differences between β-2 agonists
Session: Similarities and differences between β-2 agonists
Session type: Thematic Poster Session
Number: 1840
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. E. A. C. Broeders, J. Schalkwijk, J. Molema, H. T. M. Folgering (Groesbeek, The Netherlands). Is flow dependent dose delivery of a salbutamol-Turbuhaler clinically relevant in asthma patients?. Eur Respir J 2003; 22: Suppl. 45, 1840

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Volume response are more significant and important than flow response to bronchodilator in patients with COPD
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009


Do different combinations of bronchodilator therapies have different effects on health status in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003

COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing of therapy but was dependent on baseline gas transfer
Source: Annual Congress 2008 - Management of COPD
Year: 2008

Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020

Patients with COPD prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils?
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020

What constitutes a “clinically significant” bronchodilator response in children?
Source: Eur Respir J, 55 (5) 2000207; 10.1183/13993003.00207-2020
Year: 2020



What influences the response to training of inhalation technique in patients with asthma and COPD?
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018

Resource utilization and economic impact of switching uncontrolled asthma and exacerbating COPD patients on monotherapy to fixed dose combination treatment in Germany
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

Spanish consensus on the characteristics of severe asthmatic patients under biological treatment suitable for at home administration
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection
Source: International Congress 2018 – Asthma management
Year: 2018




COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020


Influence of gender on health status response to long-term oxygen therapy in very severe COPD patients
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009


A clinically significant bronchodilator response in children: how should it be measured?
Source: Eur Respir J, 55 (5) 2000636; 10.1183/13993003.00636-2020
Year: 2020



Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007


Can the use of adaptive aerosol delivery technology increase the quality of life for patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007

How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017


Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009


The influence of smoking on the treatment response in patients with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007

Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children
Source: Eur Respir J 2003; 21: 1007-1011
Year: 2003